# Developing Itvisma for Broad-Range Treatment of SMA with Novartis' Dr. Norman Putzki

Page: https://stenobird.com/podcast/cell-gene-the-podcast-4048431/developing-itvisma-for-broad-range-treatment-of-sma-with-novartis-dr-norman-putzki
Text version: https://stenobird.com/podcast/cell-gene-the-podcast-4048431/developing-itvisma-for-broad-range-treatment-of-sma-with-novartis-dr-norman-putzki.md
Podcast: [Cell & Gene: The Podcast](https://stenobird.com/podcast/cell-gene-the-podcast-4048431)
Published: 2026-01-01T11:00:00+00:00
Episode link: https://www.buzzsprout.com/1810482/episodes/18398477-developing-itvisma-for-broad-range-treatment-of-sma-with-novartis-dr-norman-putzki.mp3
Audio file: https://www.buzzsprout.com/1810482/episodes/18398477-developing-itvisma-for-broad-range-treatment-of-sma-with-novartis-dr-norman-putzki.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/cell-gene-the-podcast-4048431/episodes/developing-itvisma-for-broad-range-treatment-of-sma-with-novartis-dr-norman-putzki
Duration seconds: 1265

## Resource

We love to hear from our listeners. Send us a message. In episode 119 of Cell & Gene The Podcast, Host Erin Harris talks to Dr. Norman Putzki, Global Head Clinical Development, Novartis, about the FDA approval of Itvisma, now the only gene replacement therapy approved for children, adolescents, and adults with spinal muscular atrophy (SMA). Dr. Putzki walks us through the six-year development journey behind the STEER and STRENGTH Phase 3 programs. And we explore what the expanded age-rang...

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/cell-gene-the-podcast-4048431/episodes/developing-itvisma-for-broad-range-treatment-of-sma-with-novartis-dr-norman-putzki/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/cell-gene-the-podcast-4048431/developing-itvisma-for-broad-range-treatment-of-sma-with-novartis-dr-norman-putzki.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.